[Correlation between immunological markers and clinical course of HIV infection]

Insights

Human immunodeficiency virus (HIV) infection damages CD4+ T cells, leading to immunodeficiency. Laboratory markers can predict disease progression and improve clinical management of HIV/AIDS.

Area of Science:

  • Immunology
  • Virology
  • Pathogenesis

Context:

  • Human immunodeficiency virus (HIV) infects CD4+ T cells, critical for immune regulation.
  • This interaction initiates HIV pathogenesis, leading to severe immunodeficiency.
  • Monitoring CD4+ T cell count and function is vital in HIV infection.

Purpose:

  • To explore the relationship between laboratory markers and the clinical course of HIV infection.
  • To identify predictors for disease progression towards acquired immunodeficiency syndrome (AIDS).
  • To highlight the utility of these markers in managing HIV-infected individuals.

Summary:

  • HIV interaction with CD4 molecules is central to pathogenesis.
  • Decreased CD4+ T cells cause immunodeficiency.
  • Laboratory markers, categorized into viral production, immune response, immune activation, and immune damage, correlate with clinical outcomes.
  • These markers aid in predicting HIV progression to AIDS.

Impact:

  • Predicting HIV infection progression using laboratory markers can enhance clinical management.
  • Understanding these markers allows for timely interventions and improved patient outcomes.
  • This approach supports personalized medicine strategies in HIV care.